Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Small
Harold Kim

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.
Plos Medicine|December 7, 2020
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analysesEmma Rose McGlone, Iain Carey, Vladica Veličković, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol"Marcus S Shaker, John Oppenheimer, Mitchell Grayson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 1, 2020
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology ClinicMarcus S Shaker, John Oppenheimer, Mitchell Grayson, et al.
Canadian Respiratory Journal|July 16, 2004
Adult Asthma Consensus Guidelines update 2003Catherine Lemière, Tony Bai, Meyer Balter, et al.
Practical Radiation Oncology|February 18, 2018
Managing motion in conventionally fractionated lung cancer radiation therapy: Collaborative quality improvement from a statewide consortium of academic and community practicesMartha M Matuszak, Peter Paximadis, Mark Yudelev, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.
Plos Medicine|December 7, 2020
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analysesEmma Rose McGlone, Iain Carey, Vladica Veličković, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol"Marcus S Shaker, John Oppenheimer, Mitchell Grayson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 1, 2020
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology ClinicMarcus S Shaker, John Oppenheimer, Mitchell Grayson, et al.
Canadian Respiratory Journal|July 16, 2004
Adult Asthma Consensus Guidelines update 2003Catherine Lemière, Tony Bai, Meyer Balter, et al.
Practical Radiation Oncology|February 18, 2018
Managing motion in conventionally fractionated lung cancer radiation therapy: Collaborative quality improvement from a statewide consortium of academic and community practicesMartha M Matuszak, Peter Paximadis, Mark Yudelev, et al.
Pageof 22